Drug profile · INN
pazopanib hydrochloride
VOTRIENT
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
pazopanib hydrochloride (VOTRIENT) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN pazopanib hydrochloride
Brand VOTRIENT
Route ORAL
Formulation TABLET
Originator Teva Pharma GmbH
Frequently asked questions
What is pazopanib hydrochloride?
pazopanib hydrochloride (VOTRIENT) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for pazopanib hydrochloride?
VOTRIENT is a marketed brand name for pazopanib hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pazopanib hydrochloride?
pazopanib hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.